Augtyro (repotrectinib) - BMS
Rozlytrek (entrectinib) - Roche
Xalkori (crizotinib) - Pfizer
zidesamtinib (NVL-520) - Nuvalent
Ibtrozi (taletrectinib) - Nuvation Bio
Lorbrena (lorlatinib) - Pfizer
http://www.ncbi.nlm.nih.gov/pubmed/41294688
 
Christos Chouaid; Hervé Bischoff; Laura Somme; Roland Schott; Sébastien Gendarme
 
Nov 26, 2025
 
Next